Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer.

about

Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer.

Item

http://www.wikidata.org/entity/Q37467757

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Time course of Graves' orbitop ...... ne therapy for thyroid cancer.

@en

Time course of Graves' orbitop ...... ne therapy for thyroid cancer.

@nl

type

Item

label

Time course of Graves' orbitop ...... ne therapy for thyroid cancer.

@en

Time course of Graves' orbitop ...... ne therapy for thyroid cancer.

@nl

prefLabel

Time course of Graves' orbitop ...... ne therapy for thyroid cancer.

@en

Time course of Graves' orbitop ...... ne therapy for thyroid cancer.

@nl

P1476

Time course of Graves' orbitop ...... ine therapy for thyroid cancer

@en

P2093

Antony Kelly

http://www.w3.org/2001/XMLSchema#string

Beatrice Roche

http://www.w3.org/2001/XMLSchema#string

Bruno Pereira

http://www.w3.org/2001/XMLSchema#string

Camille Louvet

http://www.w3.org/2001/XMLSchema#string

Claire Bournaud

http://www.w3.org/2001/XMLSchema#string

Francoise Desbiez

http://www.w3.org/2001/XMLSchema#string

Igor Tauveron

http://www.w3.org/2001/XMLSchema#string

Marie Batisse-Lignier

http://www.w3.org/2001/XMLSchema#string

P2860

Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Graves' disease, thyroid nodules and thyroid cancer.

Development of Thyroid-Associated Ophthalmopathy in Patients Who Underwent Total Thyroidectomy.

Risk factors for development or deterioration of Graves' ophthalmopathy

The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.

Graves ophthalmopathy after radiation treatment of thyroid cancer.

Is Recombinant Human TSH a Trigger for Graves' Orbitopathy?

Clinical practice. Graves' ophthalmopathy.

P304

e5474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000005474

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salwan Maqdasy

Annamaria De Bellis

Francoise Borson-Chazot

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27902601

http://www.w3.org/2001/XMLSchema#string

P932

5134772

http://www.w3.org/2001/XMLSchema#string